COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature

被引：20

作者：

Aksoy, Elif ^{[1
]}

Oztutgan, Turgut ^{[1
]}

机构：

[1] Kolan Int Hosp, Dept Pulmonol, Darulaceze Cd 14, TR-34384 Istanbul, Turkey

来源：

CASE REPORTS IN INFECTIOUS DISEASES | 2020年 / 2020卷

关键词：

THYMECTOMY;

D O I：

10.1155/2020/8845844

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Currently, there are scarce data on how COVID-19 affects people with myasthenia gravis. Theoretically, there is a higher risk of experiencing severe manifestations of COVID-19 due to the common use of immunosuppressive drugs and potential respiratory failure in relation to respiratory muscle weakness. This is one of the early cases of COVID-19 reported in association with myasthenia gravis. Here, we highlight the prognosis, discuss the pathophysiological mechanisms, and prompt the consideration of convalescent plasma therapy in myasthenia gravis patients with concomitant COVID-19.

引用

页数：4

共 20 条

[1] Use of Convalescent Plasma Therapy in Two COVID-19 Patients With Acute Respiratory Distress Syndrome in Korea
Ahn, Jin Young
Sohn, Yujin
Lee, Su Hwan
Cho, Yunsuk
Hyun, Jong Hoon
Baek, Yae Jee
Jeong, Su Jin
Kim, Jung Ho
Ku, Nam Su
Yeom, Joon-Sup
Roh, Juhye
Ahn, Mi Young
Chin, Bum Sik
Kim, Young Sam
Lee, Hyukmin
Yong, Dongeun
Kim, Hyun Ok
Kim, Sinyoung
Choi, Jun Yong
[J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (14)
[2] Covid-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?
Amiral, Jean
Vissac, Anne Marie
Seghatchian, Jerard
[J]. TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (03)
[3] COVID-19 in patients with myasthenia gravis
Anand, Pria
Slama, Michael C. C.
Kaku, Michelle
Ong, Charlene
Cervantes-Arslanian, Anna M.
Zhou, Lan
David, William S.
Guidon, Amanda C.
[J]. MUSCLE & NERVE, 2020, 62 (02) : 254 - 258
[4] Immunotherapy in myasthenia gravis in the era of biologics
Dalakas, Marinos C.
[J]. NATURE REVIEWS NEUROLOGY, 2019, 15 (02) : 113 - 124
[5] Myasthenic crisis in COVID-19
Delly, Fadi
Syed, Maryam J.
Lisak, Robert P.
Zutshi, Deepti
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 414
[6] Diurno F, 2020, EUR REV MED PHARMACO, V24, P4040, DOI 10.26355/eurrev_202004_20875
[7] Inhibition of IL-6 overproduction by steroid treatment before transsternal thymectomy for myasthenia gravis: does it help stabilize perioperative condition?
Endo, S
Hasegawa, T
Sato, Y
Otani, S
Saito, N
Tetsuka, K
Tezuka, Y
Sohara, Y
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (10) : 768 - 773
[8] COVID-19 and neuromuscular disorders
Guidon, Amanda C.
Amato, Anthony A.
[J]. NEUROLOGY, 2020, 94 (22) : 959 - 969
[9] Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
Jacob, Saiju
Muppidi, Srikanth
Guidon, Amanda
Guptill, Jeffrey
Hehir, Michael
Howard, James F., Jr.
Illag, Isabel
Mantegazza, Renato
Murai, Hiroyuki
Utsugisawa, Kimiaki
Vissing, John
Wiendl, Heinz
Nowak, Richard J.
[J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 412
[10] A glimpse into the eye of the COVID-19 cytokine storm
Kuppalli, Krutika
Rasmussen, Angela L.
[J]. EBIOMEDICINE, 2020, 55

← 1 2 →